EFErika L. Fuchs

Erika L. Fuchs

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Erika L. Fuchs has a total of 48 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Pelvic Organ Prolapse and Alpha-1 Antitrypsin Deficiency

    by Erika Fuchs, Jennifer Cera, Kristen E. Holm, Charlie Strange, Robert Sandhaus, Isuzu Meyer, Alexandra J. Hergenrader, Derek Kruse, Immad Munawar, Yeongjin Gwon, et al.

    Background: Alpha-1 antitrypsin deficiency (AATD) is a genetic condition that increases the risk of emphysema and chronic obstructive pulmonary disease (COPD). Increased intra-abdominal pressure associated with chronic cough and damage to connective tissues that support pelvic organs suggest an association between COPD and pelvic organ prolapse (POP), a condition with estimated population prevalence of 3–6%. This study examined the prevalence of symptomatic POP among women with AATD. Methods: Women ≥18 years with AATD were invited to participate in a survey in 2025. The Pelvic Organ Prolapse Distress Inventory 6 (POPDI-6) assessed POP. Data were linked to previous survey responses including age, AATD genotype, the Chronic Airways Assessment Test (CAAT), body mass index, smoking, employment, lung disease, alpha-1 antitrypsin augmentation prescribed, and sleep apnea. Dichotomized POPDI-6 scores (>17 versus ≤17) were assessed by participant characteristics using chi-squared tests, Fisher’s exact tests, Wilcoxon–Mann–Whitney tests, and logistic regression. Results: Of those invited to participate, 921 (36.1%) individuals completed the survey. POPDI-6 scores ( n = 917) were right-skewed, and 22.1% reported significant symptom distress (POPDI-6 > 17). There were significant differences in dichotomized POPDI-6 scores by age, sleep apnea, hysterectomy, surgery, number of vaginal births, and AATD genotype. Women with POPDI-6 >17 had higher overall and cough CAAT scores than those ≤17. No significant differences emerged for other characteristics. In adjusted logistic regression, there were increased odds of POPDI-6 >17 with three or more vaginal births, a diagnosis of sleep apnea, increasing CAAT score, and a genotype of MZ, but decreased odds of POPDI-6 >17 with increasing age. Conclusions: The prevalence of POP among women with AATD was higher than that estimated in the general population. Further studies are warranted to confirm this observation. Screening of women with AATD for POP may be an opportunity to identify needs for pelvic floor therapy and education.

  • Open Access

    Wearable Activity Tracking Device Use in an Adolescent Weight Management Clinic: A Randomized Controlled Pilot Trial

    by Kanika Bowen-Jallow, Omar Nunez-Lopez, Alex Wright, Erika Fuchs, Mollie Ahn, Elizabeth Lyons, Daniel Jupiter, Lindsey Berry, Oscar Suman, Ravi S. Radhakrishnan, et al.

    Background. The use of physical activity tracker devices has increased within the general population. However, there is limited medical literature studying the efficacy of such devices in adolescents with obesity. In this study, we explored the feasibility of using wearable activity tracking devices as an adjunct intervention on adolescents with obesity. Methods. Randomized controlled pilot trial evaluated the feasibility (attrition 50) of an activity tracking intervention (ATI) and its effects on weight loss in adolescents with obesity enrolled in an adolescent weight management clinic (AWMC). Outcomes included feasibility (attrition rate) and absolute change in BMI. Differences between groups at 6, 12, and 18 weeks were examined. Results. Forty-eight participants were enrolled in the study. Eighteen subjects were randomly assigned to the ATI group and 30 to control. The average age was 14.5 years. Overall, the majority of participants were Hispanic (56). Sexes were equally distributed. The average baseline BMI was 37.5kg/m2. At the study conclusion, the overall attrition rate was 52.1, 44.4 in the ATI group versus 56.6 in the control group, with a differential attrition of 12.2. The ATI and control groups each showed an absolute decrease in BMI of 0.25 and 2.77, respectively, with no significant differences between the groups. Conclusion. The attrition rate in our study was >50. Participation in the AWMC by the ATI and control groups resulted in maintenance of BMI and body weight for the study duration. However, the use of an activity tracking device was not associated with greater weight loss. This trial is registered with NCT03004378.


  • Open Access

    Infant vaccination education preferences among low-income pregnant women

    by Erika L. Fuchs, Jacqueline M. Hirth, Fangjian Guo, V. Gnaukita Brown, Leslie Cofie, Abbey B. Berenson

    Childhood vaccination is an important public health intervention, yet many children remain under-vaccinated. The objective of this study was to examine infant vaccination education preferences in a population of low-income pregnant women by ethnicity, nativity, and language. Pregnant women 14–44 y old (n = 335) attending a participating low-income reproductive health clinic in southeast Texas from May 26-July 21, 2017, and who completed a paper survey offered in English and Spanish were included. Participants were asked to complete questions about their demographic characteristics and preferences about infant vaccination education. To examine differences in vaccine education preferences by participant demographic characteristics, chi-squared tests, or Fisher’s exact tests and one-way analysis of variance (ANOVA) were conducted using Stata SE Version 15.1 with α = 0.05. Nearly half (47.5%) of participants considered pregnancy the best time to get information about infant vaccination and were most likely (40.6%) to indicate the nurse who gives vaccines during pregnancy as the health-care worker with whom they would like to discuss infant vaccination. There were no demographic differences in preferred timing of vaccine education delivery or provider who delivers vaccine education. Prenatal, nurse-delivered vaccine educational programs would be well accepted in this low-income population.


  • Open Access

    BRCA testing in unaffected young women in the United States, 2006‐2017

    by Fangjian Guo, Matthew Scholl, Erika L. Fuchs, Abbey B. Berenson, Yong‐Fang Kuo

    Background: The discovery of the BRCA gene in the 1990s created an opportunity for individualized cancer prevention. BRCA testing in young women before cancer onset enables early detection of those with an increased cancer risk and creates an opportunity to offer lifesaving prophylactic procedures and medications. This study assessed trends in BRCA testing in women younger than 40 years without diagnosed breast or ovarian cancer (unaffected young women [UYW]) for cancer prevention between 2006 and 2017 in the United States.Methods: This study included 93,278 adult women 18 to 65 years old with insurance claims for BRCA testing between 2006 and 2017 from the de‐identified Optum Clinformatics Data Mart database. The data contained medical claims and administrative information from privately insured individuals in the United States. The proportion of BRCA testing in UYW younger than 40 years among adult women aged 18 to 65 years who received BRCA testing was assessed.Results: In 2006, only 10.5% of the tests were performed in UYW. The proportion of BRCA tests performed in UYW increased significantly to 25.5% in 2017 (annual percentage change for the 2006‐2017 period, 6.9; 95% confidence interval, 6.4‐7.3; P < .001). The increased trend in the proportion of BRCA tests in UYW significantly differed by region of residence and family history of breast or ovarian cancer.Conclusions: Over the past decade, there was increased use of BRCA testing for cancer prevention. Additional efforts are needed to maximize the early detection of women with BRCA pathogenic variants so that these cancers may be prevented.


  • Prenatal vaccination of mothers and hepatitis B vaccination of their infants

    by Erika L. Fuchs, Jonathan M. Starkey, Richard E. Rupp, Abbey B. Berenson


  • Variations in reason for intention not to vaccinate across time, region, and by race/ethnicity, NIS-Teen (2008–2016)

    by Jacqueline M. Hirth, Erika L. Fuchs, Mihyun Chang, Maria E. Fernandez, Abbey B. Berenson


  • Outcomes for Gestational Carriers Versus Traditional Surrogates in the United States

    by Erika L. Fuchs, Abbey B. Berenson

    Background: Little is known about the obstetric and procedural outcomes of traditional surrogates and gestational carriers. Materials and Methods: Participants included 222 women living in the United States who completed a brief online survey between November 2015 and February 2016. Differences between gestational carriers ( n = 204) and traditional surrogates ( n = 18) in demographic characteristics, pregnancy outcomes, and procedural outcomes were examined using chi-squared tests, Fisher's exact tests, and t -tests. Results: Out of 248 eligible respondents, 222 surveys were complete, for a response rate of 89.5%. Overall, obstetric outcomes were similar among gestational carriers and traditional surrogates. Traditional surrogates were more likely than gestational carriers to have a Center for Epidemiologic Studies Depression Scale Revised score of 16 or higher (37.5% vs. 4.0%). Gestational carriers reported higher mean compensation ($27,162.80 vs. $17,070.07) and were more likely to travel over 400 miles (46.0% vs. 0.0%) than traditional surrogates. Conclusions: Procedural differences, but not differences in obstetric outcomes, emerged between gestational carriers and traditional surrogates. To ensure that both traditional surrogates and gestational carriers receive optimal medical care, it may be necessary to extend practice guidelines to ensure that traditional surrogates are offered the same level of care offered to gestational carriers.


  • Prevention Practices among United States Pregnant Women Who Travel to Zika Outbreak Areas

    by Abbey B. Berenson, Scott C. Weaver, Erika L. Fuchs, Fangjian Guo, Jacqueline M. Hirth

    We surveyed pregnant women from the United States to assess the prevention practices they used when traveling to countries with ongoing Zika virus (ZIKV) outbreaks. Of the 749 who agreed to participate, 710 completed the survey's travel questions and 59 of those had traveled to a ZIKV outbreak area in the past 12 months. Only 43% of the women who had traveled to ZIKV outbreak areas reported frequently using mosquito repellant with 32% stating they did not use it at all. They also did not frequently use other recommended methods to prevent mosquito bites. With the established risks to babies born to women who contract the ZIKV during pregnancy, it is a great concern that a large number of women who travel to outbreak areas during pregnancy are not protecting themselves against mosquito bites. Pregnant women need to be educated on the importance of taking precautions.


  • Knowledge and Prevention Practices among U.S. Pregnant Immigrants from Zika Virus Outbreak Areas

    by Abbey B. Berenson, Ha N. Trinh, Jacqueline M. Hirth, Fangjian Guo, Erika L. Fuchs, Scott C. Weaver

    We administered an anonymous survey to assess knowledge, attitudes, and prevention practices related to the Zika virus among pregnant women residing in Texas. Multivariate logistic regression models controlling for age, race/ethnicity, education, and number of years in the United States assessed differences between women born in outbreak areas (N = 390) versus those born in the United States (N = 249). Results demonstrated that most women wanted more information on the Zika virus and desired to obtain it from their physician. The majority did not know that the Zika virus could be spread through sex with an asymptomatic partner or how often those infected were symptomatic. Few women took precautions to avoid mosquito bites. Only 40% reported frequently using repellent; 21% stated that cost was problematic and almost half were concerned about use during pregnancy. Three-fourths stated they would agree to vaccination, if available. Compared with U.S.-born women, those born in outbreak areas were more likely to have already discussed the Zika virus with their doctor (adjusted odds ratio [aOR] = 1.86, 95% confidence interval [CI] = 1.27, 2.71) and identify microcephaly as the most common birth defect (aOR = 2.59, 95% CI = 1.78, 3.76). Moreover, women born in outbreak areas were less likely to desire to keep it a secret if they became infected (aOR = 0.47, 95% CI = 0.31, 0.71). This study found that, regardless of birthplace, pregnant women need more education on the Zika virus disease and assurance regarding the safety of using repellent during pregnancy. They also need financial assistance for repellent, especially if living in states where transmission by mosquitos has been reported.


  • Screening of gestational carriers in the United States

    by Erika L. Fuchs, Abbey B. Berenson